Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial. [electronic resource]
Producer: 20200626Description: 186-195 p. digitalISSN:- 1549-4713
- Aged
- Aged, 80 and over
- Complement C3 -- antagonists & inhibitors
- Complement Inactivating Agents -- therapeutic use
- Female
- Fluorescein Angiography
- Geographic Atrophy -- diagnosis
- Humans
- Intravitreal Injections
- Macular Degeneration -- complications
- Male
- Middle Aged
- Prospective Studies
- Tomography, Optical Coherence
- Visual Acuity -- physiology
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.